KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Cash & Equivalents: 2019-2025

Historic Cash & Equivalents for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $111.1 million.

  • Ginkgo Bioworks Holdings' Cash & Equivalents fell 81.98% to $111.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.1 million, marking a year-over-year decrease of 81.98%. This contributed to the annual value of $561.6 million for FY2024, which is 40.52% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Cash & Equivalents stood at $111.1 million for Q3 2025, which was down 45.44% from $203.6 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' 5-year Cash & Equivalents high stood at $1.7 billion for Q3 2021, and its period low was $111.1 million during Q3 2025.
  • In the last 3 years, Ginkgo Bioworks Holdings' Cash & Equivalents had a median value of $730.4 million in 2024 and averaged $698.3 million.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Cash & Equivalents surged by 483.80% in 2022 and then crashed by 81.98% in 2025.
  • Ginkgo Bioworks Holdings' Cash & Equivalents (Quarterly) stood at $1.6 billion in 2021, then decreased by 15.11% to $1.3 billion in 2022, then decreased by 28.25% to $944.1 million in 2023, then tumbled by 40.52% to $561.6 million in 2024, then plummeted by 81.98% to $111.1 million in 2025.
  • Its last three reported values are $111.1 million in Q3 2025, $203.6 million for Q2 2025, and $312.4 million during Q1 2025.